Interpretation of Biomarkers of Bone Metabolism in Children: Impact of Growth Velocity and Body Size in Healthy Children and Chronic Disease
Objectives
To determine the effects of growth, maturation, and whole body bone mineral content (WB-BMC) accrual on biomarkers of bone formation (bone-specific alkaline phosphatase [BSAP]) and resorption (urine deoxypyridinoline/creatinine [DPD]) in healthy children and children with Crohn's disease.
Study design
BSAP and DPD were measured at baseline, with growth and dual energy x-ray absorptiometry (DXA) WB-BMC measured at baseline and 6 months in 202 control subjects and 110 subjects with Crohn's disease, ages 5 to 21 years. Multivariable linear regression identified determinants of biomarkers in control subjects and subjects with Crohn's disease.
Results
In control subjects, BSAP and DPD were significantly and independently associated with sex, Tanner stage, WB-BMC, height velocity, and WB-BMC accrual rates; these covariates explained 77% to 80% of the variability in the bone biomarkers, respectively. Subjects with Crohn's disease had lower height-for-age (P < .001) and WB-BMC-for-height (P <.05) than control subjects. Crohn's disease was associated with lower BSAP (P < .001) and greater DPD (P < .001), independent of growth, maturation, baseline WB-BMC, and WB-BMC accrual, compared with control subjects.
Conclusions
These data illustrate the potential confounding effects of growth and WB-BMC on bone metabolism biomarkers in children. After adjustment for these effects, Crohn's disease was associated with lower biomarkers of bone formation and greater bone resorption.
Abbreviations: BMI, Body mass index, BSAP, Bone-specific alkaline phosphatase, CV, Coefficient of variation, DPD, Urine deoxypyridinoline to creatinine ratio, DXA, Dual energy x-ray absorptiometry, IL-1β, Interleukin-1β, NFκB, Nuclear factor κB, OPG, Osteoprotegerin, PCDAI, Pediatric Crohn's Disease Activity Index, RANKL, Receptor activator of the NFκB ligand, TNF-α, Tumor necrosis factor-α, WB-BMC, Whole body bone mineral content, WB-LM, Whole body lean mass
To access this article, please choose from the options below
Supported by a grant from the National Institutes of Health (R01 DK60030) and the Clinical and Translational Research Center (UL1-RR024134) at the Children's Hospital of Philadelphia and the University of Pennsylvania School of Medicine. The authors declare no conflicts of interest.
PII: S0022-3476(08)00304-1
doi:10.1016/j.jpeds.2008.04.028
© 2008 Mosby, Inc. All rights reserved.
Refers to article:
- The Growing Skeleton is a Busy Place—Can Biochemical Bone Markers Keep Track of the Action?
